Publicaciones en colaboración con investigadores/as de University of Bari Aldo Moro (1)

2021

  1. Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial

    The Lancet, Vol. 398, Núm. 10300, pp. 583-598